China Universal Asset Management Co., Ltd. Century Therapeutics, Inc. Transaction History

China Universal Asset Management Co., Ltd.

$893 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$2.0 - $3.23 $1,494 - $2,412	747 Added 95.65%	1,528 $3,000
Q3 2023 Oct 30, 2023	BUY	$2.0 - $3.23 $1,494 - $2,412	747 Added 95.65%	1,528 $3,000
Q2 2023 May 21, 2024	SELL	$2.91 - $3.53 $52 - $63	-18 Reduced 2.25%	781 $2,000
Q2 2023 Jul 27, 2023	SELL	$2.91 - $3.53 $52 - $63	-18 Reduced 2.25%	781 $2,000
Q1 2023 May 21, 2024	BUY	$3.4 - $5.11 $680 - $1,022	200 Added 33.39%	799 $2,000
Q1 2023 Apr 27, 2023	BUY	$3.4 - $5.11 $680 - $1,022	200 Added 33.39%	799 $3,000
Q4 2022 May 21, 2024	BUY	$4.84 - $11.58 $2,899 - $6,936	599 New	599 $3,000
Q4 2022 Jan 31, 2023	BUY	$4.84 - $11.58 $232 - $555	48 Added 8.71%	599 $3,000
Q3 2022 Oct 21, 2022	BUY	$8.57 - $13.1 $4,722 - $7,218	551 New	551 $5,000

Others Institutions Holding IPSC

# of Institutions

Shares Held

36.9M

Call Options Held

8.7K

Put Options Held

10.2K

Bain Capital Life Sciences Investors, LLC Boston, MA

5.41M
Shares

$7.3 Million
1.66% of portfolio
Vr Adviser, LLC New York, NY

5.39M
Shares

$7.28 Million
0.95% of portfolio
Boxer Capital, LLC San Diego, CA

3.9M
Shares

$5.27 Million
0.35% of portfolio
Casdin Capital, LLC New York, NY

3.21M
Shares

$4.34 Million
0.43% of portfolio
Black Rock Inc. New York, NY

2.9M
Shares

$3.91 Million
0.0% of portfolio

View Full List

About Century Therapeutics, Inc.

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $79.5M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

More about IPSC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account